Assessment of Cost-awareness and Likelihood to Consider Costs for Postoperative Nausea and Vomiting Medications in a Military Anesthesia Department

J Perianesth Nurs. 2022 Dec;37(6):815-819. doi: 10.1016/j.jopan.2021.12.007. Epub 2022 Jun 9.

Abstract

Purpose: To evaluate the impact of an informational presentation on acquisition cost-awareness and likelihood to consider acquisition costs for post-operative nausea and vomiting (PONV) medications among military anesthesia providers.

Design: A descriptive, longitudinal survey was conducted between March 9, 2020, and April 3, 2020.

Methods: Military anesthesia providers (n = 12) estimated the institutional acquisition costs of 9 PONV-related medications and rated their likelihood to consider costs before and after an informational presentation.

Findings: Nine paired surveys were completed and returned. After an informational presentation, providers significantly improved estimation accuracy for 4 medications and significantly increased the likelihood to consider costs.

Conclusions: A survey evaluation highlighted deficiencies in acquisition cost-awareness and likelihood to consider acquisition costs for PONV medications among military anesthesia providers that improved after an informational presentation.

Keywords: PONV; cost-awareness; military anesthesia.

MeSH terms

  • Anesthesia Department, Hospital
  • Anesthesia*
  • Anesthesiology*
  • Antiemetics* / therapeutic use
  • Humans
  • Military Personnel*
  • Postoperative Nausea and Vomiting / drug therapy

Substances

  • Antiemetics